Uncategorized

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says – CNBC

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says  CNBCOzempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trial  CNNFor Alzheimer’s patients, Novo Nordisk GLP-1 drug slows cognitive decline: study  MarketWatchCan Weight Loss Drugs Like Ozempic Protect Brains And Stave Off Alzheimer’s? New Research Suggests They Can.  ForbesOzempic-like weight loss drugs may protect against Alzheimer’s  NBC News